Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund News: Clifton Robbins, Barry Rosenstein, Stanley Druckenmiller

Page 1 of 2

Activist Unveils Bank Investment (CNBC)
Activist investor Clifton Robbins thinks buying stock in Investors Bancorp is a near-sure way to make money. “This is one of the best risk return investments I’ve seen,” the CEO of hedge fund Blue Harbour Group said Monday at the 13D Monitor Active-Passive Investor Summit in New York. Blue Harbour is a $3.7 billion hedge fund firm that focuses on friendly collaboration with the companies it invests in, unlike some of its more confrontational activist peers.

Clifton Robbins - Blue Harbour

Activist Jana Calls for Qualcomm to Weigh Chip Unit Spinoff (Bloomberg)
Qualcomm Inc. should consider spinning off its chipset business as part of a strategic review of options to boost shareholder value, activist investor Barry Rosenstein said. Separating the unit, which makes chips for mobile phones, could make it a takeover target, Rosenstein said Monday at 13D Monitor’s Active-Passive Investor Summit in New York. Rosenstein’s Jana Partners, which has invested more than $2 billion in Qualcomm, has held talks with the company’s management, he said.

Druckenmiller: This Could End ‘Very Badly’ (CNBC)
Billionaire investor Stanley Druckenmiller has once again warned that the easy money policies of recent years could end poorly. “I know it’s so tempting to go ahead and make investments and it looks good for today,” the retired founder of Duquense Capital Management said, “but when this thing ends, because we’ve had speculation, we’ve had money building up four to six years in terms of a risk pattern, I think it could end very badly.”

Zoetis Adds Second Director Under Deal With Pershing Square (Reuters)
Animal health products company Zoetis Inc added a second independent director to its board under an agreement it reached with Bill Ackman‘s hedge fund Pershing Square Capital Management in February. Zoetis appointed Actavis Plc Executive Chairman and former chief executive Paul Bisaro as an independent director, the company said on Monday. Zoetis agreed with Pershing Square and Sachem Head Group in February to add two independent directors.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!